OpenURL Connection Search

Select item for more details and to access through your institution.

Therapeutic implications of novel mutations of the RFX6 gene associated with early-onset diabetes.
Published in:
Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 49, doi. 10.1038/tpj.2014.37
By:
- Artuso, R;
- Provenzano, A;
- Mazzinghi, B;
- Giunti, L;
- Palazzo, V;
- Andreucci, E;
- Blasetti, A;
- Chiuri, R M;
- Gianiorio, F E;
- Mandich, P;
- Monami, M;
- Mannucci, E;
- Giglio, S
Publication type:
Article
Clonal Transmission of ESBL-Producing Klebsiella spp. at a University Hospital in Brazil.
Published in:
Current Microbiology, 2008, v. 56, n. 6, p. 587, doi. 10.1007/s00284-008-9129-5
By:
- Minarini, Luciene A. R.;
- Clímaco, Eduardo C.;
- Guimarães, Daniela B.;
- Ferreira, Joseane C.;
- Palazzo, Izabel C. V.;
- Martinez, Roberto;
- Darini, Ana Lúcia C.
Publication type:
Article
Prevalence of Community-Occurring Extended Spectrum β-Lactamase-Producing Enterobacteriaceae in Brazil.
Published in:
Current Microbiology, 2007, v. 54, n. 5, p. 335, doi. 10.1007/s00284-006-0307-z
By:
- Minarini, Luciene A. R.;
- Gales, Ana C.;
- Palazzo, Izabel C. V.;
- Darini, Ana Lúcia C.
Publication type:
Article
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma.
Published in:
2016
By:
- Cereda, S.;
- Milella, M.;
- Cordio, S.;
- Leone, F.;
- Aprile, G.;
- Galiano, A.;
- Mosconi, S.;
- Vasile, E.;
- Santini, D.;
- Belli, C.;
- Auriemma, A.;
- Novarino, A.;
- Vaccaro, V.;
- Martines, C.;
- Marino, D.;
- Lutrino, S.;
- Palazzo, V.;
- Reinach, B.;
- Aldrighetti, L.;
- Reni, M.
Publication type:
journal article

Found: 4

Therapeutic implications of novel mutations of the RFX6 gene associated with early-onset diabetes.

Clonal Transmission of ESBL-Producing Klebsiella spp. at a University Hospital in Brazil.

Prevalence of Community-Occurring Extended Spectrum β-Lactamase-Producing Enterobacteriaceae in Brazil.

Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma.